Skip to main content

Table 1 Participant characteristics

From: Plasma 25-hydroxyvitamin D level and the risk of frailty among Chinese community-based oldest-old: evidence from the CLHLS study

Variables

All participants (n = 1324)

Categories (nmol/L)

Statistics a

Q1 (≤26.13)

Q2 (26.13–35.89)

Q3 (35.89–50.00)

Q4 (> 50.00)

Socio-demographics, n (%)

 Age (80–112), M (SD)

92.89 (7.92)

95.63 (7.49)

93.37 (7.72)

91.85 (7.85)

90.70 (7.78)

25.207***

 Female

844 (63.7)

251 (75.8)

236 (71.3)

200 (60.2)

157 (47.6)

68.190***

 Married

294 (22.3)

44 (13.3)

60 (18.2)

83 (25.1)

107 (32.7)

40.503***

 Rural

1124 (84.9)

282 (85.2)

282 (85.2)

265 (79.8)

295 (89.4)

11.925**

 No schooling

998 (76.4)

279 (85.8)

257 (78.4)

242 (74.2)

220 (67.1)

33.410***

 With household member(s)

950 (73.2)

263 (82.2)

236 (72.2)

225 (69.7)

226 (69.1)

25.873***

Health characteristics, n (%)

 Smoking

148 (11.3)

28 (8.5)

39 (11.8)

37 (11.2)

44 (13.5)

4.337

 Drinking

167 (12.7)

32 (9.7)

41 (12.5)

45 (13.6)

49 (14.9)

0.218

 Regular exercise

178 (13.9)

27 (8.4)

38 (11.9)

54 (16.7)

59 (18.6)

17.317***

 Hypertension

785 (62.2)

197 (61.9)

195 (62.1)

192 (61.5)

201 (63.0)

0.155

 Diabetes mellitus

98 (7.4)

28 (8.5)

25 (7.6)

24 (7.3)

21 (6.4)

1.057

 Heart diseases

91 (7.0)

24 (7.4)

24 (7.4)

27 (8.4)

16 (4.9)

3.398

 Cerebrovascular diseases

102 (7.8)

34 (10.4)

31 (9.5)

18 (5.5)

19 (5.8)

8.630*

 Respiratory diseases

116 (8.9)

29 (9.0)

32 (9.8)

23 (7.0)

32 (9.8)

2.080

Biomarkers, M (IQR)

 CRP (mg/L)

1.01 (0.41,2.93)

1.12 (0.38,3.35)

0.93 (0.43,3.05)

0.96 (0.41,2.54)

1.09 (0.39,2.75)

1.491

 ALB (g/L)

39.10 (35.90,42.40)

37.90 (35.30,41.40)

38.60 (35.48,42.12)

39.70 (36.70,42.93)

39.90 (37.20,42.80)

29.923***

 CHO (mmol/L)

4.16 (3.52,4.79)

4.03 (3.49,4.72)

4.21 (3.51,4.79)

4.21 (3.47,4.97)

4.20 (3.70,4.78)

4.186

 CREA (mmol/L)

78 (65,96)

69 (60,85)

77 (63,93)

82 (69,98)

87 (71,102)

76.765***

 HDLC (mmol/L)

1.23 (1.03,1.49)

1.20 (1.01,1.45)

1.25 (1.04,1.51)

1.27 (1.03,1.55)

1.23 (1.04,1.46)

5.065

 LDLC (mmol/L)

2.45 (1.94,3.02)

2.40 (1.92,2.97)

2.42 (1.89,3.05)

2.41 (1.86,3.08)

2.54 (2.04,3.00)

5.147

 TG (mmol/L)

0.79 (0.59,1.10)

0.78 (0.59,1.07)

0.79 (0.58,1.09)

0.82 (0.61,1.16)

0.77 (0.57,1.07)

6.429

 SOD (IU/mL)

58.53 (53.43,63.24)

56.75 (51.75,62.97)

58.18 (53.49,63.20)

58.75 (53.33,63.06)

59.39 (55.39,64.24)

18.975***

 MDA (μmol/L)

4.71 (3.73,5.79)

4.81 (3.93,5.89)

4.87 (3.88,5.91)

4.84 (3.82,5.83)

4.33 (3.25,5.55)

27.303***

 WBC (109/L)

5.30 (4.30,6.40)

4.80 (4.00,6.00)

5.10 (4.10,6.10)

5.60 (4.57,6.60)

5.60 (5.60,6.80)

34.983***

 HGB (g/L)

118 (106,131)

121 (110,133)

120 (107,132)

116 (105,129)

117 (105,131)

11.618***

Frailty, n (%)

426 (33.2)

162 (48.9)

112 (33.8)

93 (28.0)

59 (17.9)

76.606***

  1. M (SD) mean (standard deviation), M (IQR) median (interquartile range)
  2. a Coefficient of ANOVA, Kruskal–Wallis test or χ2 test among categories of plasma 25(OH) D level
  3. * < 0.05, ** < 0.01, *** < 0.001
  4. Abbreviations: CRP C reactive protein, ALB plasma albumin, CHO total cholesterol, CREA plasma creatine, HDLC high-density lipoprotein cholesterol, LDLC low-density lipoprotein cholesterol, SOD superoxide dismutase, TG triglyceride, SOD superoxide dismutase, MDA malondialdehyde, WBC white blood cell count, HGB haemoglobin